
INmune Bio Inc. (INMB)
- Previous Close
2.3600 - Open
2.4000 - Bid 1.7600 x 200
- Ask 3.0000 x 200
- Day's Range
2.3500 - 2.4400 - 52 Week Range
1.0900 - 2.4800 - Volume
263,845 - Avg. Volume
724,771 - Market Cap (intraday)
67.442M - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6200 - Earnings Date (est.) Oct 29, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
Recent News
View MorePerformance Overview
Trailing total returns as of 8/25/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
67.44M
-
Enterprise Value
50.44M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
708.07
-
Price/Book (mrq)
2.89
-
Enterprise Value/Revenue
286.00
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-39.12%
-
Return on Equity (ttm)
-74.82%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-18.42M
-
Diluted EPS (ttm)
-0.6200
Balance Sheet and Cash Flow
-
Total Cash (mrq)
18.41M
-
Total Debt/Equity (mrq)
6.90%
-
Levered Free Cash Flow (ttm)
-10.05M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.




